Citius Oncology (CTOR) vs Rafael (RFL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Rafael (RFL) has outperformed Citius Oncology (CTOR) over the past year, gaining 20.3% versus a loss of 54.1%. Citius Oncology is the larger company by market cap ($88.8 million vs $83.2 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTOR | RFL |
|---|---|---|
| Share price | $0.8398 | $1.60 |
| Market cap | $88.82M | $83.20M |
| 1-day change | +0.57% | +8.11% |
| YTD return | -16.02% | +35.59% |
| 1-year return | -54.11% | +20.30% |
| 5-year return | — | -94.69% |
| EPS (TTM) | $-0.48 | $-0.72 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.25 | $3.96 |
| 52-week low | $0.491 | $1.12 |
| Distance from 52-week high | -62.68% | -59.60% |
| Analyst consensus | none | — |
| Avg. price target upside | +376.30% | — |
| Average volume | 100.32K | 159.84K |
| Shares outstanding | 105.76M | 51.21M |
| Employees | — | 21 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RFL has outperformed CTOR by 74.4 percentage points over the past year.
About Citius Oncology
CTOR stock →Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies.
Health Care · Biotechnology: Pharmaceutical Preparations
About Rafael
RFL stock →Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel.
Health Care · Biotechnology: Pharmaceutical Preparations · 21 employees
CTOR vs RFL FAQ
Which is bigger, Citius Oncology or Rafael?
Citius Oncology (CTOR) is larger, with a market capitalization of $88.82M compared with $83.20M for Rafael (RFL).
Which stock has performed better over the past year, CTOR or RFL?
RFL returned +20.30% over the past 12 months, compared with -54.11% for CTOR (price return, excluding dividends). Past performance does not predict future results.
Are Citius Oncology and Rafael in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.